| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. (SRPT) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 20 sells. SRPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 659.8K | $13.17M | - | |
| Pres | 226.3K | $4.52M | - | |
| COO | 202.0K | $4.03M | - | |
| VP | 138.9K | $2.77M | - | |
| CFO | 135.1K | $2.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Estepan Ian Michael75 | Chief Operating Officer | Sell | 13,187 | $22.31 | $294,201.97 | -6.4% | -25.3% | - | |
| Mar 12, 2025 | Nicaise Claude | Director | Sale+OE | 2,491 | $99.64 | $248,203.24 | -8.2% | -60.8% | -82.9% | |
| Dec 12, 2024 | Wigzell Hans Lennart Rudolf60 | Director | Sale+OE | 10,500 | $124.84 | $1,310,820.00 | -31.5% | -19.8% | -82.7% | |
| Dec 5, 2024 | Boor Kathryn Jean | Director | Sell | 1,636 | $125.55 | $205,399.80 | -21.8% | -14.7% | -82.4% | |
| Aug 30, 2024 | Estepan Ian Michael75 | Chief Financial Officer | Sell | 5,985 | $137.36 | $822,099.60 | -15.0% | -1.8% | -86.6% | |
| Aug 16, 2024 | Chambers Michael Andrew56 | Director | Buy | 37,038 | $133.80 | $4,955,728.14 | +4.7% | -18.2% | -83.7% | |
| Jun 25, 2024 | Brown Ryan Edward | EVP, General Counsel | Sale+OE | 38,957 | $161.61 | $6,296,029.42 | -13.9% | -21.0% | -89.0% | |
| Jun 25, 2024 | Arif Bilal77 | Chief Tech Ops Officer | Sale+OE | 11,757 | $163.13 | $1,917,891.11 | -8.4% | -21.0% | -89.0% | |
| May 2, 2024 | Murray Dallan | Chief Customer Officer | Sell | 3,635 | $140.00 | $508,900.00 | -16.7% | +8.9% | -51.4% | |
| Mar 11, 2024 | Boor Kathryn Jean | Director | Sell | 761 | $122.93 | $93,549.73 | -9.2% | +0.8% | -17.2% |